| Basics |
|
TransMedics Group, Inc.
|
| IPO Date: |
April 29, 2019 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$4.1B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.45 | 2.81%
|
| Avg Daily Range (30 D): |
$2.44 | 2.11%
|
| Avg Daily Range (90 D): |
$2.61 | 2.18%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
.78M |
| Avg Daily Volume (90 D): |
.91M |
| Trade Size |
| Avg Trade Size (Sh.): |
50 |
| Avg Trade Size (Sh.) (30 D): |
36 |
| Avg Trade Size (Sh.) (90 D): |
37 |
| Institutional Trades |
| Total Inst.Trades: |
2,826 |
| Avg Inst. Trade: |
$3.56M |
| Avg Inst. Trade (30 D): |
$6.7M |
| Avg Inst. Trade (90 D): |
$5.73M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.72M |
| Avg Closing Trade (30 D): |
$8.64M |
| Avg Closing Trade (90 D): |
$8.72M |
| Avg Closing Volume: |
64.38K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
|
$1.03
|
$.76
|
|
Diluted EPS
|
|
$.92
|
$.7
|
|
Revenue
|
$
|
$ 157.37M
|
$ 143.54M
|
|
Gross Profit
|
$
|
$ 96.59M
|
$ 88.23M
|
|
Net Income / Loss
|
$
|
$ 34.91M
|
$ 25.68M
|
|
Operating Income / Loss
|
$
|
$ 36.57M
|
$ 27.44M
|
|
Cost of Revenue
|
$
|
$ 60.78M
|
$ 55.31M
|
|
Net Cash Flow
|
$
|
$ 90.43M
|
$ -26.51M
|
|
PE Ratio
|
|
|
|
|
|
|